Constitutional epimutation as a mechanism for cancer causality and heritability?

Nature Reviews Cancer

Volumn 15, Issue 10, 2015, Pages 625-634

  Hitchins, Megan P ^a  

^a STANFORD CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; DEATH ASSOCIATED PROTEIN KINASE 1; EPITHELIAL CELL ADHESION MOLECULE; PROTEIN MLH1; PROTEIN MSH2; UNCLASSIFIED DRUG;

CANCER MORTALITY; CARCINOGENESIS; CONSTITUTIONAL EPIMUTATION; EPIGENETICS; GENE DELETION; GENE MUTATION; GENOME IMPRINTING; H19 GENE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HERITABILITY; HUMAN; IMPRINTING CONTROL REGION; INHERITANCE; NEOPLASM; NEPHROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR GENE; GENETIC PREDISPOSITION; GENETICS; HEREDITY; MUTATION;

EPIGENOMICS; GENETIC PREDISPOSITION TO DISEASE; HEREDITY; HUMANS; MUTATION; NEOPLASMS;

EID: 84942366655     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc4001     Document Type: Review

References (117)

1. Eichler, E. E., et al. Missing heritability and strategies for finding the underlying causes of complex disease. Nat. Rev. Genet. 11, 446-450 (2010
2. Maher, B. Personal genomes: the case of the missing heritability. Nature 456, 18-21 (2008
3. Petronis, A. Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature 465, 721-727 (2010
4. McCarthy, M. I., & Hirschhorn, J. N. Genome-wide association studies: potential next steps on a genetic journey. Hum. Mol. Genet. 17, R156-R165 (2008
5. Jones, P. A., & Baylin, S. B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415-428 (2002
6. Feinberg, A. P., & Vogelstein, B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301, 89-92 (1983
7. Feinberg, A. P., & Vogelstein, B. Hypomethylation of ras oncogenes in primary human cancers. Biochem. Biophys. Res. Commun. 111, 47-54 (1983
8. De Smet, C., et al. The activation of human gene MAGE 1 in tumor cells is correlated with genome-wide demethylation. Proc. Natl Acad. Sci. USA 93, 7149-7153 (1996
9. Cho, B., et al. Promoter hypomethylation of a novel cancer/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma. Biochem. Biophys. Res. Commun. 307, 52-63 (2003
10. Gama-Sosa, M. A., et al. The 5 methylcytosine content of DNA from human tumors. Nucleic Acids Res. 11, 6883-6894 (1983
11. Eden, A., Gaudet, F., Waghmare, A., & Jaenisch, R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300, 455 (2003
12. Hansen, K. D., et al. Increased methylation variation in epigenetic domains across cancer types. Nat. Genet. 43, 768-775 (2011
13. Greger, V., Passarge, E., Hopping, W., Messmer, E., & Horsthemke, B. Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum. Genet. 83, 155-158 (1989
14. Gonzalez-Zulueta, M., et al. Methylation of the 5? CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 55, 4531-4535 (1995
15. Graff, J. R., et al. E cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res. 55, 5195-5199 (1995
16. Cunningham, J. M., et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. 58, 3455-3460 (1998
17. Veigl, M. L., et al. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc. Natl Acad. Sci. USA 95, 8698-8702 (1998
18. Kane, M. F., et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 57, 808-811 (1997
19. Toyota, M., et al. CpG island methylator phenotype in colorectal cancer. Proc. Natl Acad. Sci. USA 96, 8681-8686 (1999
20. Weisenberger, D. J., et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat. Genet. 38, 787-793 (2006
21. Hinoue, T., et al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res. 22, 271-282 (2012
22. Noushmehr, H., et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17, 510-522 (2010
23. Shih, A. H., Abdel-Wahab, O., Patel, J. P., & Levine, R. L. The role of mutations in epigenetic regulators in myeloid malignancies. Nat. Rev. Cancer 12, 599-612 (2012
24. Esteller, M., et al. DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum. Mol. Genet. 10, 3001-3007 (2001
25. Steenman, M. J., et al. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nat. Genet. 7, 433-439 (1994
26. Goelz, S. E., Vogelstein, B., Hamilton, S. R., & Feinberg, A. P. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 228, 187-190 (1985
27. Cui, H., Horon, I. L., Ohlsson, R., Hamilton, S. R., & Feinberg, A. P. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat. Med. 4, 1276-1280 (1998
28. Fernando, W. C., et al. The CIMP phenotype in BRAF mutant serrated polyps from a prospective colonoscopy patient cohort. Gastroenterol. Res. Pract. 2014, 374926 (2014
29. Hawkins, N. J., et al. MGMT methylation is associated primarily with the germline CT SNP (rs16906252) in colorectal cancer and normal colonic mucosa. Mod. Pathol. 22, 1588-1599 (2009
30. Wong, J. J., Hawkins, N. J., Ward, R. L., & Hitchins, M. P. Methylation of the 3p22 region encompassing MLH1 is representative of the CpG island methylator phenotype in colorectal cancer. Mod. Pathol. 24, 396-411 (2011
31. Cho, N. Y., Kim, J. H., Moon, K. C., & Kang, G. H. Genomic hypomethylation and CpG island hypermethylation in prostatic intraepithelial neoplasm. Virchows Arch. 454, 17-23 (2009
32. Cui, H., et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 299, 1753-1755 (2003
33. Ito, Y., et al. Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer. Hum. Mol. Genet. 17, 2633-2643 (2008
34. Pufulete, M., et al. Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology 124, 1240-1248 (2003
35. Slaughter, D. P., Southwick, H. W., & Smejkal, W. 'Field cancerization' in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer 6, 963-968 (1953
36. Candiloro, I. L., & Dobrovic, A. Detection of MGMT promoter methylation in normal individuals is strongly associated with the T allele of the rs16906252 MGMT promoter single nucleotide polymorphism. Cancer Prev. Res. 2, 862-867 (2009
37. Fuke, C., et al. Age related changes in 5 methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based study. Ann. Hum. Genet. 68, 196-204 (2004
38. Bjornsson, H. T., et al. Intra-individual change over time in DNA methylation with familial clustering. JAMA 299, 2877-2883 (2008
39. Kwabi-Addo, B., et al. Age-related DNA methylation changes in normal human prostate tissues. Clin. Cancer Res. 13, 3796-3802 (2007
40. Heyn, H., et al. Linkage of DNA methylation quantitative trait loci to human cancer risk. Cell Rep. 7, 331-338 (2014
41. Li, Q., et al. Integrative eQTL-based analyses reveal the biology of breast cancer risk loci. Cell 152, 633-641 (2013
42. Rapkins, R. W., et al. The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide. Neuro Oncol. http:/dx.doi. org/10.1093/neuonc/nov064 (2015
43. Brennan, K., & Flanagan, J. M. Is there a link between genome-wide hypomethylation in blood and cancer risk? Cancer Prev. Res. 5, 1345-1357 (2012
44. Huang, W. Y., et al. Prospective study of genomic hypomethylation of leukocyte DNA and colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev. 21, 2014-2021 (2012
45. Nan, H., et al. Pre-diagnostic leukocyte genomic DNA methylation and the risk of colorectal cancer in women. PLoS ONE 8, e59455 (2013
46. Holliday, R. The inheritance of epigenetic defects. Science 238, 163-170 (1987
47. Hitchins, M. P., & Ward, R. L. Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer. J. Med. Genet. 46, 793-802 (2009
48. van Overveld, P. G., et al. Hypomethylation of D4Z4 in 4q linked and non 4q linked facioscapulohumeral muscular dystrophy. Nat. Genet. 35, 315-317 (2003
49. Horsthemke, B. Epimutations in human disease. Curr. Top. Microbiol. Immunol. 310, 45-59 (2006
50. Hesson, L. B., Hitchins, M. P., & Ward, R. L. Epimutations and cancer predisposition: importance and mechanisms. Curr. Opin. Genet. Dev. 20, 290-298 (2010
51. Oey, H., & Whitelaw, E On the meaning of the word 'epimutation'. Trends Genet. 30, 519-520 (2014
52. Moulton, T., et al. Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nat. Genet. 7, 440-447 (1994
53. Moulton, T., et al. Genomic imprinting and Wilms' tumor. Med. Pediatr. Oncol. 27, 476-483 (1996
54. Engel, J. R., et al. Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome. J. Med. Genet. 37, 921-926 (2000
55. DeBaun, M. R., et al. Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am. J. Hum. Genet. 70, 604-611 (2002
56. Cooper, W. N., et al. Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome. Eur. J. Hum. Genet. 13, 1025-1032 (2005
57. Scott, R. H., et al. Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor. Nat. Genet. 40, 1329-1334 (2008
58. Cerrato, F., et al. Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour. Hum. Mol. Genet. 17, 1427-1435 (2008
59. Murrell, A., et al. Distinct methylation changes at the IGF2 H19 locus in congenital growth disorders and cancer. PLoS ONE 3, e1849 (2008
60. Ravenel, J. D., et al. Loss of imprinting of insulin-like growth factor II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor. J. Natl Cancer Inst. 93, 1698-1703 (2001
61. Lynch, H. T., Snyder, C. L., Shaw, T. G., Heinen, C. D., & Hitchins, M. P. Milestones of Lynch syndrome: 1895-2015. Nat. Rev. Cancer 15, 181-194 (2015
62. Miyakura, Y., et al. Extensive but hemiallelic methylation of the hMLH1 promoter region in early-onset sporadic colon cancers with microsatellite instability. Clin. Gastroenterol. Hepatol. 2, 147-156 (2004
63. Suter, C. M., Martin, D. I., & Ward, R. L. Germline epimutation of MLH1 in individuals with multiple cancers. Nat. Genet. 36, 497-501 (2004
64. Hitchins, M., et al. MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer. Gastroenterology 129, 1392-1399 (2005
65. Hitchins, M. P., et al. Inheritance of a cancer-Associated MLH1 germ-line epimutation. N. Engl. J. Med. 356, 697-705 (2007
66. Gazzoli, I., Loda, M., Garber, J., Syngal, S., & Kolodner, R. D. A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor. Cancer Res. 62, 3925-3928 (2002
67. Hitchins, M. P. The role of epigenetics in Lynch syndrome. Fam. Cancer 12, 189-205 (2013
68. Goel, A., et al. De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one. Int. J. Cancer 128, 869-878 (2011
69. Hitchins, M. P., & Lynch, H. T. Dawning of the epigenetic era in hereditary cancer. Clin. Genet. 85, 413-416 (2014
70. Pineda, M., et al. MLH1 methylation screening is effective in identifying epimutation carriers. Eur. J. Hum. Genet. 20, 1256-1264 (2012
71. van Roon, E. H., et al. Early onset MSI H colon cancer with MLH1 promoter methylation, is there a genetic predisposition? BMC Cancer 10, 180 (2010
72. Pinheiro, H., et al. Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer. Hum. Mol. Genet. 19, 943-952 (2010
73. Snell, C., Krypuy, M., Wong, E. M., Loughrey, M. B., & Dobrovic, A. BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype. Breast Cancer Res. 10, R12 (2008
74. Hansmann, T., et al. Constitutive promoter methylation of BRCA1 and RAD51C in patients with familial ovarian cancer and early-onset sporadic breast cancer. Hum. Mol. Genet. 21, 4669-4679 (2012
75. Galetzka, D., et al. Monozygotic twins discordant for constitutive BRCA1 promoter methylation, childhood cancer and secondary cancer. Epigenetics 7, 47-54 (2012
76. Wong, E. M., et al. Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-Associated pathology in early-onset breast cancer. Cancer Prev. Res. 4, 23-33 (2011
77. Wojdacz, T. K., Thestrup, B. B., Cold, S., Overgaard, J., & Hansen, L. L. No difference in the frequency of locus-specific methylation in the peripheral blood DNA of women diagnosed with breast cancer and age-matched controls. Future Oncol. 7, 1451-1455 (2011
78. Sparago, A., et al. Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome. Nat. Genet. 36, 958-960 (2004
79. Chan, T. L., et al. Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer. Nat. Genet. 38, 1178-1183 (2006
80. Ligtenberg, M. J., et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3? exons of TACSTD1. Nat. Genet. 41, 112-117 (2009
81. Kuiper, R. P., et al. Recurrence and variability of germline EPCAM deletions in Lynch syndrome. Hum. Mutat. 32, 407-414 (2011
82. Kempers, M. J., et al. Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. Lancet Oncol. 12, 49-55 (2011
83. Lynch, H. T., et al. Lynch syndrome-Associated extracolonic tumors are rare in two extended families with the same EPCAM deletion. Am. J. Gastroenterol. 106, 1829-1836 (2011
84. Hitchins, M. P., et al. Dominantly inherited constitutional epigenetic silencing of MLH1 in a cancer-Affected family is linked to a single nucleotide variant within the 5?UTR. Cancer Cell 20, 200-213 (2011
85. Kwok, C. T., et al. The MLH1 c.-27CA and c.85GT variants are linked to dominantly inherited MLH1 epimutation and are borne on a European ancestral haplotype. Eur. J. Hum. Genet. 22, 617-624 (2014
86. Morak, M., et al. Biallelic MLH1 SNP cDNA expression or constitutional promoter methylation can hide genomic rearrangements causing Lynch syndrome. J. Med. Genet. 48, 513-519 (2011
87. Raval, A., et al. Downregulation of death-Associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 129, 879-890 (2007
88. Hitchins, M., et al. Germline epimutations of APC are not associated with inherited colorectal polyposis. Gut 55, 586-587 (2006
89. van Doorn, R., Zoutman, W. H., & Gruis, N. A. Absence of germline epimutation of the CDKN2A gene in familial melanoma. J. Invest. Dermatol. 129, 781-784 (2009
90. Hyland, P. L., et al. Constitutional promoter methylation and risk of familial melanoma. Epigenetics 9, 685-692 (2014
91. Nag, A., et al. Chromatin signature of widespread monoallelic expression. elLfe 2, e01256 (2013
92. Cubas, P., Vincent, C., & Coen, E. An epigenetic mutation responsible for natural variation in floral symmetry. Nature 401, 157-161 (1999
93. Manning, K., et al. A naturally occurring epigenetic mutation in a gene encoding an SBP-box transcription factor inhibits tomato fruit ripening. Nat. Genet. 38, 948-952 (2006
94. Pal-Bhadra, M., et al. Heterochromatic silencing and HP1 localization in Drosophila are dependent on the RNAi machinery. Science 303, 669-672 (2004
95. Morgan, H. D., Sutherland, H. G., Martin, D. I., & Whitelaw, E. Epigenetic inheritance at the agouti locus in the mouse. Nat. Genet. 23, 314-318 (1999
96. Rakyan, V. K., et al. Transgenerational inheritance of epigenetic states at the murine AxinFu allele occurs after maternal and paternal transmission. Proc. Natl Acad. Sci. USA 100, 2538-2543 (2003
97. Feng, S., Jacobsen, S. E., & Reik, W. Epigenetic reprogramming in plant and animal development. Science 330, 622-627 (2010
98. Heijmans, B. T., et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc. Natl Acad. Sci. USA 105, 17046-17049 (2008
99. DeBaun, M. R., Niemitz, E. L., & Feinberg, A. P. Association of in vitro fertilization with Beckwith-Wiedemann syndrome and epigenetic alterations of LIT1 and H19. Am. J. Hum. Genet. 72, 156-160 (2003
100. Hiura, H., et al. Characterization of DNA methylation errors in patients with imprinting disorders conceived by assisted reproduction technologies. Hum. Reprod. 27, 2541-2548 (2012
101. Casati, L., Sendra, R., Sibilia, V., & Celotti, F. Endocrine disrupters: the new players able to affect the epigenome. Front. Cell Dev. Biol. http:/dx.doi. org/10.3389/fcell.2015.00037 (2015
102. Xin, F., Susiarjo, M., & Bartolomei, M. S. Multigenerational and transgenerational effects of endocrine disrupting chemicals: a role for altered epigenetic regulation? Semin. Cell Dev. Biol. http:/dx. doi.org/10.1016/j.semcdb.2015.05.008 (2015
103. Manikkam, M., Tracey, R., Guerrero-Bosagna, C., & Skinner, M. K. Dioxin (TCDD) induces epigenetic transgenerational inheritance of adult onset disease and sperm epimutations. PLoS ONE 7, e46249 (2012
104. Manikkam, M., Haque, M. M., Guerrero-Bosagna, C., Nilsson, E. E., & Skinner, M. K. Pesticide methoxychlor promotes the epigenetic transgenerational inheritance of adult-onset disease through the female germline. PLoS ONE 9, e102091 (2014
105. Iqbal, K., et al. Deleterious effects of endocrine disruptors are corrected in the mammalian germline by epigenome reprogramming. Genome Biol. 16, 59 (2015
106. Bygren, L. O., Kaati, G., & Edvinsson, S. Longevity determined by paternal ancestors' nutrition during their slow growth period. Acta Biotheor 49, 53-59 (2001
107. Kaati, G., Bygren, L. O., & Edvinsson, S. Cardiovascular and diabetes mortality determined by nutrition during parents' and grandparents' slow growth period. Eur. J. Hum. Genet. 10, 682-688 (2002
108. Chen, T. H., Chiu, Y. H., & Boucher, B. J. Transgenerational effects of betel-quid chewing on the development of the metabolic syndrome in the Keelung Community-based Integrated Screening Program. Am. J. Clin. Nutr. 83, 688-692 (2006
109. Kaati, G., Bygren, L. O., Pembrey, M., & Sjostrom, M. Transgenerational response to nutrition, early life circumstances and longevity. Eur. J. Hum. Genet. 15, 784-790 (2007
110. Grossniklaus, U., Kelly, W. G., Ferguson-Smith, A. C., Pembrey, M., & Lindquist, S. Transgenerational epigenetic inheritance: how important is it? Nat. Rev. Genet. 14, 228-235 (2013
111. Stoger, R., Kajimura, T. M., Brown, W. T., & Laird, C. D. Epigenetic variation illustrated by DNA methylation patterns of the fragile X gene FMR1. Hum. Mol. Genet. 6, 1791-1801 (1997
112. Hitchins, M. P., & Ward, R. L. Erasure of MLH1 methylation in spermatozoa-implications for epigenetic inheritance. Nat. Genet. 39, 1289 (2007
113. Slatkin, M. Epigenetic inheritance and the missing heritability problem. Genetics 182, 845-850 (2009
114. Furrow, R. E., Christiansen, F. B., & Feldman, M. W. Environment-sensitive epigenetics and the heritability of complex diseases. Genetics 189, 1377-1387 (2011
115. Heyn, H., et al. DNA methylation contributes to natural human variation. Genome Res. 23, 1363-1372 (2013
116. Smallwood, S. A., et al. Dynamic CpG island methylation landscape in oocytes and preimplantation embryos. Nat. Genet. 43, 811-814 (2011
117. Santos, F., Hendrich, B., Reik, W., & Dean, W. Dynamic reprogramming of DNA methylation in the early mouse embryo. Dev. Biol. 241, 172-182 (2002